Nisbet M, Briggs S, Ellis-Pegler R, Thomas M, Holland D
Infectious Disease Department, Auckland City Hospital, Private Bag 92024, Auckland, New Zealand.
J Antimicrob Chemother. 2007 Nov;60(5):1097-103. doi: 10.1093/jac/dkm351. Epub 2007 Sep 17.
Propionibacterium acnes is increasingly recognized as a cause of post-neurosurgical infection. This review of patients with P. acnes neurosurgical infection was carried out in order to determine clinical characteristics and outcomes in relation to duration of antimicrobial treatment.
We retrospectively reviewed the charts of consecutive patients with P. acnes isolated from neurosurgical specimens from 1 January 1999 to 30 June 2005. We defined P. acnes neurosurgical infection as isolation of P. acnes alone from a sterile neurosurgical site in a patient who clinically improved following treatment with an appropriate antibiotic.
We identified 28 patients with definite P. acnes neurosurgical infection; median age 49 years (range 23-77); 15 (54%) male. All patients had prior neurosurgical procedures: 27 (96%) post-craniotomy. The median time from surgery to presentation was 54 days (range 12-1,578). Eighteen out of 28 (64%) patients who met the definition of neurosurgical infection had Gram-positive bacilli seen in at least one surgical specimen compared with only 2/56 (4%) patients who did not meet the definition (P < 0.0001). Intravenous benzyl penicillin +/- oral penicillin VK was the most common treatment. The median duration of antibiotic treatment for intracranial infection was 29 days. Five of nine patients who had extracranial bone-flap-associated infection had <or=7 days of intravenous treatment and were cured. Two patients had relapse or reinfection.
P. acnes neurosurgical infection often presents in an indolent fashion. Gram-positive bacilli on Gram stain should not be discounted as a contaminant in neurosurgical specimens. Associated bone flaps should be removed. Intravenous benzyl penicillin +/- oral penicillin VK remains effective treatment.
痤疮丙酸杆菌日益被认为是神经外科手术后感染的病因。对痤疮丙酸杆菌神经外科感染患者进行本综述,以确定与抗菌治疗持续时间相关的临床特征和结局。
我们回顾性分析了1999年1月1日至2005年6月30日期间从神经外科标本中分离出痤疮丙酸杆菌的连续患者的病历。我们将痤疮丙酸杆菌神经外科感染定义为在接受适当抗生素治疗后临床症状改善的患者中,从无菌神经外科部位单独分离出痤疮丙酸杆菌。
我们确定了28例明确的痤疮丙酸杆菌神经外科感染患者;中位年龄49岁(范围23 - 77岁);15例(54%)为男性。所有患者均有既往神经外科手术史:27例(96%)为开颅术后。从手术到出现感染的中位时间为54天(范围12 - 1578天)。在符合神经外科感染定义的28例患者中,有18例(64%)在至少一份手术标本中发现革兰氏阳性杆菌,而在不符合定义的56例患者中仅有2例(4%)发现(P < 0.0001)。静脉注射苄星青霉素±口服青霉素V钾是最常用的治疗方法。颅内感染的抗生素治疗中位持续时间为29天。9例颅外骨瓣相关感染患者中有5例接受了≤7天的静脉治疗并治愈。2例患者出现复发或再感染。
痤疮丙酸杆菌神经外科感染通常呈隐匿性表现。革兰氏染色发现的革兰氏阳性杆菌在神经外科标本中不应被视为污染物而被忽视。应切除相关骨瓣。静脉注射苄星青霉素±口服青霉素V钾仍然是有效的治疗方法。